EUVIMEDEUVIMED entdecken
Crossref

Regulatory Provisions for Introducing Phytopharmaceutical Drugs in Indian Market

Anshita Anshita, Anshu Dalal, Gobind Yadav, Arun Nanda

Pharmacognosy Reviews · 01.01.2027 · 21 (41) · 79-97

DOI: 10.5530/phrev.20270080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacognosy Reviews, online erschienen am 01.01.2027. Verfasst von Anshita Anshita und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Anshita, A., Dalal, A., Yadav, G., & Nanda, A. (2027). Regulatory Provisions for Introducing Phytopharmaceutical Drugs in Indian Market. Pharmacognosy Reviews, 21(41), 79-97. https://doi.org/10.5530/phrev.20270080

Vancouver

Anshita A, Dalal A, Yadav G, Nanda A. Regulatory Provisions for Introducing Phytopharmaceutical Drugs in Indian Market. Pharmacognosy Reviews. 2027;21(41):79-97. doi:10.5530/phrev.20270080

BibTeX
@article{Anshita2027,
  author = {Anshita, Anshita and Dalal, Anshu and Yadav, Gobind and Nanda, Arun},
  title = {Regulatory Provisions for Introducing Phytopharmaceutical Drugs in Indian Market},
  journal = {Pharmacognosy Reviews},
  year = {2027},
  volume = {21},
  number = {41},
  pages = {79--97},
  doi = {10.5530/phrev.20270080}
}
Kostenlos starten →